Breathing Disorders & Treatment Companies

ID: MRFR/Pharma/1046-HCR

90 Pages

Nidhi Mandole

Last Updated: February 16, 2025

Breathing disorders, ranging from common conditions like asthma to more severe illnesses such as chronic obstructive pulmonary disease (COPD), pose significant challenges to millions of people worldwide. As the prevalence of respiratory ailments continues to rise, there is a growing need for innovative and effective treatment options.

Breathing Disorders & Treatment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)7.0%

2024 Market Size$ 64 Billion

2025 Market Size$ 68.48 Billion

2035 Market Size$ 134.7 Billion

Key Players

Pfizer

Boehringer Ingelheim

GlaxoSmithKline

Novartis

AstraZeneca

Teva Pharmaceutical Industries

Trends

Technological Advancements in Treatment
Rise of Telehealth Solutions
Growing Preference for Home-Based Therapies

Opportunities

Aging Population
Rising Awareness and Education
Government Initiatives and Funding

Summary Table of Contents Segmentation Methodology Download PDF

Top Industry Leaders in the Breathing Disorders & Treatment Market

Breathing Disorders Treatment Key Companies

Latest Breathing Disorders Treatment Companies Update:

Philips Healthcare Announced the expansion of their BioTelemetry Platform in January 2024, enabling remote monitoring of a wider range of vital signs and physiological parameters for improved patient care, including breathing difficulties.

ResMed Launched the AirTouch™ F20 Full Face Mask in October 2023, featuring a soft and flexible design for more comfortable sleep apnea therapy.

Masimo Corporation Received FDA approval for their Radius-7 Pulse Oximeter in December 2023, offering continuous monitoring of blood oxygen saturation and pulse rate, helpful for managing breathing disorders.

Propeller Health Partnered with a major health insurance company in February 2024 to provide their Propeller Breathe digital therapeutic app for asthma management to a wider user base.

Air Liquide Announced the development of a next-generation high-flow nasal oxygen therapy (HFNO) device in November 2023, aiming to offer improved comfort and treatment efficacy for respiratory insufficiency.

List of Breathing Disorders Treatment Key companies in the market

AstraZeneca
GlaxoSmithKline
Merck Sharp & Dohme Corp.
Abbott
Medtronic plc
Hoffmann-La Roche Ltd
Novartis AG
Reddy’s Laboratories
Amgen
Aurobindo Pharma.
Bayer AG
Biogen

Customize Report

Certified Researchers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”